Coldman A - Search Results

1

Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer.

Murray N, Grafton C, Shah A, Gelmon K, Kostashuk E, Brown E, Coppin C, Coldman A, Page R. Murray N, et al. Among authors: coldman a. J Clin Oncol. 1998 Oct;16(10):3323-8. doi: 10.1200/JCO.1998.16.10.3323. J Clin Oncol. 1998. PMID: 9779708

2

Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.

Murray N, Coppin C, Coldman A, Pater J, Rapp E. Murray N, et al. Among authors: coldman a. J Clin Oncol. 1994 Nov;12(11):2333-9. doi: 10.1200/JCO.1994.12.11.2333. J Clin Oncol. 1994. PMID: 7964949 Clinical Trial.

3

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.

Klasa RJ, Murray N, Coldman AJ. Klasa RJ, et al. Among authors: coldman aj. J Clin Oncol. 1991 Mar;9(3):499-508. doi: 10.1200/JCO.1991.9.3.499. J Clin Oncol. 1991. PMID: 1847968 Clinical Trial.

4

Modelling the effect of chemotherapy intensity.

Coppin C, Coldman A, Goldie J. Coppin C, et al. Among authors: coldman a. Prog Clin Biol Res. 1990;354B:103-16. Prog Clin Biol Res. 1990. PMID: 2236160 No abstract available.

5

Immunotherapy for advanced renal cell cancer.

Coppin C, Porzsolt F, Kumpf J, Coldman A, Wilt T. Coppin C, et al. Among authors: coldman a. Cochrane Database Syst Rev. 2000;(3):CD001425. doi: 10.1002/14651858.CD001425. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001425. doi: 10.1002/14651858.CD001425.pub2 PMID: 10908496 Updated. Review.

6

Immunotherapy for advanced renal cell cancer.

Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Coppin C, et al. Among authors: coldman a. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001425. doi: 10.1002/14651858.CD001425.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Dec 29;(12):CD001425. doi: 10.1002/14651858.CD001425.pub3 PMID: 15674877 Updated. Review.

7

Calculating dose intensity.

Coldman AJ, Coppin CM. Coldman AJ, et al. J Clin Oncol. 1991 Sep;9(9):1713-4. doi: 10.1200/JCO.1991.9.9.1713. J Clin Oncol. 1991. PMID: 1875226 No abstract available.

8

Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients.

Embree L, Gelmon KA, Lohr A, Mayer LD, Coldman AJ, Cullis PR, Palaitis W, Pilkiewicz F, Hudon NJ, Heggie JR, et al. Embree L, et al. Among authors: coldman aj. J Pharm Sci. 1993 Jun;82(6):627-34. doi: 10.1002/jps.2600820617. J Pharm Sci. 1993. PMID: 8392545 Clinical Trial.

9

Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia.

Laskin JJ, Erridge SC, Coldman AJ, D'yachkova Y, Speers C, Westeel V, Hislop TG, Olivotto IA, Murray N. Laskin JJ, et al. Among authors: coldman aj. Lung Cancer. 2004 Jan;43(1):7-16. doi: 10.1016/j.lungcan.2003.07.004. Lung Cancer. 2004. PMID: 14698532

10

Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

Olivotto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, Davis GJ, Chia SK, Gelmon KA. Olivotto IA, et al. Among authors: coldman aj. J Clin Oncol. 2005 Apr 20;23(12):2716-25. doi: 10.1200/JCO.2005.06.178. J Clin Oncol. 2005. PMID: 15837986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters